IRIS
CANTATORE, FRANCESCO PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.099
EU - Europa 11.115
AS - Asia 8.000
SA - Sud America 1.376
AF - Africa 145
Continente sconosciuto - Info sul continente non disponibili 24
OC - Oceania 23
Totale 34.782
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.911
IE - Irlanda 3.084
CN - Cina 3.076
SG - Singapore 2.600
UA - Ucraina 2.119
RU - Federazione Russa 1.790
SE - Svezia 1.375
BR - Brasile 1.133
HK - Hong Kong 840
FR - Francia 665
DE - Germania 546
VN - Vietnam 472
IT - Italia 452
FI - Finlandia 410
IN - India 304
TR - Turchia 295
GB - Regno Unito 276
CZ - Repubblica Ceca 118
AR - Argentina 97
CA - Canada 92
BD - Bangladesh 65
IQ - Iraq 63
MX - Messico 61
PL - Polonia 50
EC - Ecuador 47
NL - Olanda 44
AT - Austria 41
ZA - Sudafrica 37
ID - Indonesia 36
JP - Giappone 36
BE - Belgio 33
UZ - Uzbekistan 25
PK - Pakistan 23
ES - Italia 22
EG - Egitto 20
EU - Europa 19
VE - Venezuela 19
CO - Colombia 18
MA - Marocco 18
PH - Filippine 18
CL - Cile 17
JO - Giordania 16
PY - Paraguay 16
SA - Arabia Saudita 16
AZ - Azerbaigian 14
TN - Tunisia 14
AU - Australia 13
IR - Iran 13
KE - Kenya 13
LT - Lituania 13
PE - Perù 13
RO - Romania 10
DZ - Algeria 9
NP - Nepal 9
NZ - Nuova Zelanda 9
UY - Uruguay 9
DK - Danimarca 8
CH - Svizzera 7
IL - Israele 7
JM - Giamaica 7
LB - Libano 7
PT - Portogallo 7
CI - Costa d'Avorio 6
HR - Croazia 6
KZ - Kazakistan 6
NG - Nigeria 6
OM - Oman 6
PA - Panama 6
SN - Senegal 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
ET - Etiopia 5
HU - Ungheria 5
KG - Kirghizistan 5
MY - Malesia 5
SY - Repubblica araba siriana 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AM - Armenia 4
BA - Bosnia-Erzegovina 4
BH - Bahrain 4
BO - Bolivia 4
LV - Lettonia 4
MD - Moldavia 4
PS - Palestinian Territory 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
AO - Angola 3
BG - Bulgaria 3
CR - Costa Rica 3
GT - Guatemala 3
HN - Honduras 3
MN - Mongolia 3
SK - Slovacchia (Repubblica Slovacca) 3
BY - Bielorussia 2
DO - Repubblica Dominicana 2
GA - Gabon 2
GE - Georgia 2
GR - Grecia 2
GY - Guiana 2
KR - Corea 2
Totale 34.749
Salva come PNG Salva come JPEG
Città #
Dublin 3.080
San Jose 1.967
Dallas 1.803
Jacksonville 1.420
Chandler 1.330
Singapore 1.207
Dearborn 985
Nyköping 880
Ashburn 868
Hong Kong 831
Nanjing 650
Beijing 613
Santa Clara 406
Lauterbourg 344
Wilmington 339
Princeton 324
Munich 278
San Mateo 224
Nanchang 210
Moscow 207
The Dalles 186
Helsinki 175
New York 168
Ho Chi Minh City 165
Los Angeles 164
Shenyang 148
Boardman 141
Ann Arbor 121
Hebei 113
Des Moines 107
Jiaxing 102
Brno 97
São Paulo 97
Tianjin 96
Kunming 91
Woodbridge 91
Hanoi 83
Changsha 75
Shanghai 71
Foggia 70
Guangzhou 53
Hangzhou 47
Zhengzhou 46
London 45
Frankfurt am Main 44
Jinan 42
Orem 42
Nuremberg 41
Chicago 39
Dong Ket 34
Hilden 32
Brooklyn 31
Milan 31
San Francisco 31
Ningbo 29
Baghdad 28
Norwalk 28
Tokyo 28
Brussels 27
Hillsboro 27
Taizhou 27
Rio de Janeiro 26
Warsaw 26
Lanzhou 25
Seattle 25
Washington 25
Chennai 24
Columbus 24
Curitiba 24
Stevenage 24
Guayaquil 23
Toronto 23
Turku 23
Pune 22
Tashkent 21
Amsterdam 20
Assago 20
Auburn Hills 20
Changchun 20
Da Nang 20
Falkenstein 20
Haiphong 20
Hanover 20
Manchester 20
Montreal 20
Atlanta 19
Boston 19
Belo Horizonte 18
Council Bluffs 18
Hefei 18
Rome 18
Xi'an 18
Brasília 17
Orange 17
Salvador 17
Stockholm 17
Bari 16
Redwood City 16
Johannesburg 15
Amman 14
Totale 21.871
Salva come PNG Salva come JPEG
Nome #
1,25OH-Vitamin D3 and IL-17 Inhibition Modulate Pro-Fibrotic Cytokines Production in Peripheral Blood Mononuclear Cells of Patients with Systemic Sclerosis 525
1,25OH-Vitamin D3 and IL-17 Inhibition Modulate Pro-Fibrotic Cytokines Production in Peripheral Blood Mononuclear Cells of Patients with Systemic Sclerosis 474
Visceral fat dysfunctions in the rat social isolation model of psychosis 259
Primary versus systemic sclerosis-associated Raynaud’s phenomenon: relationship with clinical and environmental factors 214
A case of rhupus treated with filgotinib: A promising therapeutic perspective 191
Transthoracic Lung Ultrasound in Systemic Sclerosis-Associated Interstitial Lung Disease: Capacity to Differentiate Chest Computed-Tomographic Characteristic Patterns 182
25-Hydroxycholecalciferol in experimental osteoporosis 172
SUBSTANCE P AND VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION BY PERIPHERAL BLOOD MONONUCLEAR CELLS DERIVING FROM PATIENTS WITH SYSTEMIC SCLEROSIS 155
Nailfold capillaroscopic findings in systemic sclerosis related lung fibrosis and in idiopathic lung fibrosis 153
Chronic psychosocial stress impairs bone homeostasis: A study in the social isolation reared rat 151
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: A EUSTAR prospective study 151
Yes-associated protein (YAP) is a negative regulator of chondrogenesis in mesenchymal stem cells 149
Extra-skeletal effects of bisphosphonates. 147
Synovial fluid fibroblasts and lymphocytes support the osteoclastogenesis in human psoriatic arthritis 144
Dose-dependent metabolic effect of zoledronate on primary human osteoblastic cell cultures. 144
Adult Scheuermann's disease as cause of mechanic dorsalgia 142
How to Assess Pulmonary Circulation and Right Heart Chambers in Systemic Sclerosis Patients? 141
Normal serum concentrations of 1,25 dihydroxyvitamin D in osteoporosis 140
A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study 138
Abnormalities of insulin-like growth factor-I signaling and impaired cell proliferation in osteoblasts from subjects with osteoporosis 137
A case of chondrodysplasia.Dolichomelic spondylo-epiphyseal chondrodysplasia 137
Effect of endothelin inhibition on lung fibroblasts on patients with systemic sclerosis 137
Two cases of distal extremity swelling with pitting oedema in psoriatic arthritis: the different pathological mechanisms. 133
Pubic symphysis sclerosis in psoriatic arthritis. Case report. 133
SUBCLINICAL ATHEROSCLEROSIS AND CARDIOVASCULAR EVENTS IN ITALIAN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS FROM MULTICENTER GIRRCS (GRUPPO ITALIANO DI RICERCA IN REUMATOLOGIA CLINICA E SPERIMENTALE) STUDY 132
Clodronate inhibits angiogenesis in vitro and in vivo 130
Effects of anabolic steroids, salmon calcitonin and 25OH-D3 on rat bones 130
Ulcerative colitis and systemic lupus erythematosus. Minerva Med 129
A comparison of the nutritional status between adult celiac patients on a long-term, strictly gluten-free diet and healthy subjects 128
Corticosteroids, a review. 127
Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFalpha, and IL-7 in an in vitro model derived from human psoriatic arthritis 126
Linear bone densitometry by monochromatic photon absorptiometry. A study of a normal population in Apulia 126
THE ROLE OF TRANSIENT ELASTOGRAPHY (FIBROSCAN) IN THE STUDY OF LIVER FIBROSIS IN SSc 125
Melkersson-Rosenthal syndrome in a patient with psoriatic arthritis receiving etanercept. 125
Small doses of etidronate (EHDP) and Paget's disease: meaning and importance of the decrease in plasmatic 25(OH)D3 124
Anti-TNF-α and risk of infections: the experience in one center. 124
COUNSELLING ON FAMILY PLANNING AND CONTRACEPTION, AND PREGNANCY OUTCOME IN WOMEN WITH RHEUMATIC DISEASES: A NATIONAL SURVEY OF 398 PATIENT-REPORTED QUESTIONNAIRES FROM 24 RHEUMATOLOGY CENTERS 124
Breast cancer cell line MDA-231 stimulates osteoclastogenesis and bone resorption in human osteoclasts 123
Evaluation of mineral metabolism and bone turnover in osteoporotic females treated withphosphorus and salmon calcitonin 123
Extracellular Matrix modulates angiogenesis in physiological and pathological conditions 123
Multiprofessional and intrahospital experience for diagnosis and treatment of pulmonary arterial hypertension 123
Anti-carbamylated protein antibodies and skin involvement in patients with systemic sclerosis: An intriguing association. 123
Efficacy and retention rate of secukinumab in psoriatic arthritis across different clinical phenotypes: insights from the Italian GISEA Registry 122
Effect of oestrogen replacement on bone metabolism and cytokines in surgical menopause 122
Bisphosphonates: effects on osteoblast. 122
Drug survival and effectiveness of ustekinumab in patients with psoriatic arthritis. Real-life data from the biologic Apulian registry (BIOPURE) 122
Role of altered osteoblastic expression of Dkk-1 in the pathogenesis of osteoarthritis and osteoporosis 121
Post biliopancreatic by-pass arthritis dermatitis syndrome 120
Beta-2 microglobulin in osteoarthrosis 120
Subspecificities of anticentromeric protein A antibodies identify systemic sclerosis patients at higher risk of pulmonary vascular disease. 120
Serum 25(OH)D3 in theApulian population (Southern Italy). Epidemiologic study 119
Bone effects of biologic drugs in rheumatoid arthritis. 119
RANKL/OPG Ratio and DKK-1 Expression in Primary Osteoblastic Cultures from Osteoarthritic and Osteoporotic Subjects 119
Anomalies de la capillaroscopie périunguéale au cours de la fibrose pulmonaire associée à la sclérodermie systémique et au cours de la fibrose pulmonaire idiopathique 119
Echographic study of Tietze's syndrome. 116
A sequential treatment of osteoporosis with anabolic steroids and salmon calcitonin 116
Combined effect of Neridronate and specific antibiotic therapy in a case of tuberculous spondylodiscitis 116
Type II diabetes in systemic sclerosis patients: insights from an observational, multicenter study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 115
Mitochondrial disease mimicking polymyositis: a case report 115
Comments on Addolorata Corrado et al. review “Extra-skeletal effects of bisphosphonates” 115
Fascite eosinofila: entità clinica a se stante o variante clinica della sclerosi sistemica? 114
Effects of nandrolonedecanoate on plasma calcitonin, parathormone and vitamin D, in elderly women 114
Metabolic effects of zoledronate on primary human osteoblastic cell cultures 114
In vitro and in vivo angiogenic activity of osteoarthritic and osteoporotic osteoblasts is modulated by VEGF and vitamin D3 treatment 114
AB0171 Anti-carbamylated protein antibodies in patients with systemic sclerosis: an intriguing association with skin involvement 114
Vitamin D and the immune system 113
Serum osteocalcin levels in normal humans of different sex and age. An epidemiological study. 113
La coxalgia 113
IgA nephropathy in systemic lupus erythematosus. 112
Juvenile idiopathic arthritis: an update on clinical and therapeutic approaches 112
Anabolic therapy of induced osteoporosisin beta-thalassaemia major: case report and literature review 112
ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis - A EUSTAR analysis 112
BIOLOGIC THERAPIES AND INFECTIONS IN THE DAILY PRACTICE: A STUDY ON HISTORICAL COHORT FROM 3 ITALIAN RHEUMATOLOGIC UNITS 111
AB0225 Clinical outcomes of treatment with golimumab in seropositive and seronegative rheumatoid arthritis patients in real-life settings. data from italian register gisea 111
Bisphosphonates and osteoarthritis 111
Monitoring biological action of rapamycin in renal transplantation. 110
Extracellular matrix interactions with osteoblasts in osteoarthritis. A preliminary report 110
Systemic effects of Wnt signaling 110
Anti-angiogenic effects of biotechnological therapies in rheumatic diseases 110
The effect of hydroxychloroquine on activities of daily living and hand function in systemic sclerosis: results from an analysis of the EUSTAR cohort 110
Efficacy of a soy rich diet in preventing postmenopausal osteoporosis: the Menfis randomized trial 109
Soluble decoy receptor 3 modulates the survival and formation of osteoclasts from multiple myeloma bone disease patients 109
Osteocytes: central conductors of bone biology in normal and pathological conditions 109
Effects of anabolic steroids, 1.25(OH)D3 and calcitonin on osteocalcin and calciotropic hormones 109
Osteocalcin: Skeletal and extra-skeletal effects 109
Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis 109
AB0253 BIOMARKERS OF CLINICAL RESPONSE TO IL6-R BLOCKADE IN DMARDS INCOMPLETE RESPONDERS (AR-BIOM TRIAL): IL23 AND BAFF AS BIOLOGICAL TARGETS, AND ALBUMIN AS BIOLOGICAL PREDICTOR 109
C-reactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women. 108
The death receptor DR5 is involved in TRAIL-mediated human osteoclast apoptosis. 108
Polymyalgia rheumatica: a systemic vasculitis. Review of the literature and presentation of 2clinical cases 108
Imaging of chondrocalcinosis: calcium pyrophosphate dihydrate (CPPD) crystal deposition disease - imaging of common sites of involvement. 108
Integrine expression on human osteoblasts in osteoarthritis 108
Bone mineral measurements in 5 to 25 year old males and females 108
Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. 108
Joint and tendon involvement predict disease progression in systemic sclerosis: A EUSTAR prospective study 108
Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: A EUSTAR analysis 108
SERUM 25(OH) VITAMIN D LEVELS, BODY MASS COMPOSITION AND EXTENT OF SKIN SCLEROSIS IN SYSTEMIC SCLEROSIS PATIENTS 108
AB1290 VITAMIN D AND PAIN SYNDROME IN BREAST CANCER PATIENTS TREATED WITH ADJUVANT LETROZOLE 108
Adipokines and Chronic Rheumatic Diseases: from Inflammation to Bone Involvement 108
Effect of calcitonin or the anabolic steroid decadurabolin on serum B2 microglobulin in osteoporotic post menopausal women 107
Totale 13.258
Salva come PNG Salva come JPEG
Categoria #
all - tutte 191.166
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 191.166
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021394 0 0 0 0 0 0 0 0 0 341 5 48
2021/20221.622 234 23 14 10 123 35 45 141 250 222 93 432
2022/20236.944 630 249 282 364 352 632 34 506 3.515 68 150 162
2023/20241.175 179 60 66 51 79 278 23 50 15 47 27 300
2024/20255.508 305 51 118 188 184 824 611 401 1.458 371 482 515
2025/202610.619 578 997 2.285 1.329 463 492 2.195 1.041 816 423 0 0
Totale 35.899